rasburicase 7.5 MG Injection

RxCUI
1790349
RxNorm name
rasburicase 7.5 MG Injection
Display name
rasburicase 7.5 MG Injection
Full name
rasburicase 7.5 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103946Elitekrasburicase351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ElitekRASBURICASESanofi-Aventis U.S. LLC0ae10bc4-6b65-402f-9db5-2d77530549222026-07-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1790349

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0ae10bc4-6b65-402f-9db5-2d7753054922rasburicase 7.5 MG InjectionSCD23These highlights do not include all the information needed to use Elitek safely and effectively. See full prescribing information for Elitek ® . ELITEK (rasburicase) for injection, for intravenous use Initial U.S. Approval: 200220250508
0ae10bc4-6b65-402f-9db5-2d7753054922rasburicase 7.5 MG InjectionPSN23These highlights do not include all the information needed to use Elitek safely and effectively. See full prescribing information for Elitek ® . ELITEK (rasburicase) for injection, for intravenous use Initial U.S. Approval: 200220250508